B6.BKS(D)-Leprdb/J mouse

Home
Services
R&D Services for Diabetes Mellitus and Diabetic Complications
Type 2 Diabetes Mellitus Research and Development Services
T2DM Modeling Service
T2DM Mouse Models
B6.BKS(D)-Leprdb/J mouse

Inquiry

ace

* First Name
* Last Name
* Business Email
Phone
Company/Institution
Job Title
* Services or Products of Interest (DMM-001241) B6.BKS(D)-Leprdb/J mouse
When do you expect your project to start?
Project Description
* All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
* Tick to confirm the Research Use Only (RUO) statement.

B6.BKS(D)-Leprdb/J mouse

Inquiry

Cat. No.: DMM-001241

Status	Age	Sex
Live Mouse Frozen Embryo	4 weeks 12 weeks Customized Age	Male Female

Model Overview
Model Description	Mice homozygous for the diabetes spontaneous mutation (Leprdb) become identifiably obese around 3 to 4 weeks of age with elevations of plasma insulin beginning at 10 to 14 days and of blood sugar at four to eight weeks. Affected mice are polyphagic, polydipsic, and polyuric.
SPF	Yes
Research Application	Diabetes

Target Information
Target Name	Lepr
Synonyms	OBR, CD295, HuB219, LEP-R
Gene ID	3953

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Related Models

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Copyright © Ace Therapeutics. All Rights Reserved.

Top